Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NCKU Research Team Developed New Stem Cell Therapy for Heart Repair, First in the World

Abstract:
Assistant Prof. Patrick C. H. Hsieh of Institute of Nanotechnology and Microsystems Engineering, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan, has led a research team of myocardial regeneration to conduct an experiment on pigs and has proved that by combining self-assembling peptide nanofiber hydrogel with autologous bone marrow stem cell, myocardial protection after acute myocardial infarction, vascular regeneration and heart functions can be improved.

NCKU Research Team Developed New Stem Cell Therapy for Heart Repair, First in the World

Taiwan | Posted on October 12th, 2010

The research achievement of the novel stem cell therapy for heart repair has been published in Circulation, the top international journal in the cardiovascular field, in September, 2010, and the technology is currently under the applications of domestic and foreign patents.

Each year, 17,000,000 people die from heart disease worldwide. In Taiwan, there are approximately 2,000,000 heart disease patients each year and 400,000 people pass away due to heart failure. The most common cause for the heart disease is coronary occlusion or myocardial infarction, preventing blood from going to the heart and thus leading to myocardial necrosis and apoptosis. The mortality rate reaches as high as 30%.

Even if the patients are fortunate to survive, their myocardial cells lack the ability to regenerate. The myocardial cells cannot take intraventricular pressure and thus they will gradually expand and become thin. Eventually, the patients will have heart failure and face death.

The best clinical treatment is heart transplant. However, due to limited heart donors and risks such as immune rejection and infection, it is not in common use. The most common clinical treatment is drug control, including ACE inhibitors, ‚-blockers, digitalis glycosides and diuretics. However, they can only slow down disease progression, and they normally have side-effects. Thus, the novel treatment method, the stem cell therapy for heart repair, has become the solution to one of the most urgent medical problems.

NCKU Assistant Prof. Patrick C. H. Hsieh pointed out, "Even though recent research studies have indicated that many types of stem cells can be used to improve heart functions and be clinically effective and secure, there is still room which needs improvement. For instance, when stem cells are cultured outside the body and injected into the heart, most of them are immediately carried away by the blood flow or they face rapid death. Even if few of them survive, they hardly become mature and functional cardiac or vascular cells, thus lack effectiveness. So far, we know that when we inject stem cells into the heart, the survival rate of the cells staying in the heart after 24 hours is less than 1%. However, by combining self-assembling peptide nanofiber hydrogel with stems cells and injecting the mixture into cardiac muscle, the stem cells will not be easily carried away from the heart by the blood. Thus, the retention rate is increased to 100%. In addition, problems such as the source, amount and exclusion of stem cells, as well as how to accurately inject stem cells into damaged parts of cardiac muscle and how to pass trials in large animal experiments to ensure safety are issues yet to be solved."

To solve the above-mentioned problems, the research team led by Assistant Prof. Patrick C. H. Hsieh has developed novel pharmaceutical compositions and treatment methods, engaged in an experiment on Lanyu miniature pig, which has similar cardiac structure to that of the human beings and used self-assembling peptide nanofiber hydrogel to inject to damaged areas of cardiac infarction, thus reducing sequelae such as ventricular wall thinning and ventricular dilation and improving diastolic dysfunction from 54.2% to 85.5% after cardiac infarction.

The self-assembling peptide nanofiber hydrogel can integrate stems cells from the bone marrow in the miniature pig to effectively prevent pathological ventricular remodeling and diastolic dysfunction, significantly improve the myocardial viability and systolic function from 65.6% to 91.4%, increase the myocardial angiogenesis from 13.7% to 46.5%, reduce the range of myocardial infarction from 18.6% to 11.3%, and even promote potential myocardial regeneration.

One of the characteristics of this research achievement is modeled on the implementation of clinical therapy, from extracting stem cells from the bone marrow and mixing it with nanofiber hydrogel to completing the surgery of cardiac injection, the process only requires 30 minutes.

Assistant Prof. Patrick C. H. Hsieh emphasized, "The time to save acute myocardial infarction patients is extremely precious. Thus a fast and effective treatment method can be applied to myocardial infarction patients in the future or provide a viable alternative to patients who are not suitable for traditional treatment methods."

Once clinical trials are completed and are developed into treatment method, it is believed that it can benefit many patients and create huge business opportunities. In general, the advantages of this discovery include simple and rapid preparation within 30 minutes, zero side-effects, zero inflammation, zero immune response and currently 0% mortality rate, and research and development potential of integrating drug release of PDGF, FGF, p38, IGF.

The breaking research achievement is funded by the 5 Year 5 Billion Project of the Ministry of Education, Taiwan, National Science Council, National Health Research Institutes, Academia Sinica and NCKU Hospital.

Facilitated by Prof. Jyh-Horung Chen, the former Superintendent of NCKU Hospital and the President of Taiwan Society of Cardiology and Prof. Hua-Lin Wu of Department of Biochemistry and Molecular Biology, the Director of Cardiovascular Research Center, the main members of the research team include Assistant Prof. Patrick C. H. Hsieh of Institute of Nanotechnology and Microsystems Engineering, Assistant Prof. Ming-Long Yeh of Institute of Biomedical Engineering, doctoral students Yi-Dong Lin and Ming-Yao Chang of Institute of Biomedical Engineering, research assistants Da-Ching Tsai, Ting-Yu Zhu, Shih-Ya Yun and Alan C.L. Tang of Stem Cell and Nano Technology Research Lab, Prof. Yu-Jen Yang of NCKU Hospital Department of Surgery, Dr. Yen-Wen Liu of NCKU Hospital Division of Cardiology, Dr. Tsai-Yun Chen of NCKU Hospital Division of Hemato-Oncology, and Dr. Kung-Chao Chang of NCKU Hospital Department of Pathology.

####

For more information, please click here

Contacts:
National Cheng Kung University
News Center
Crystal Chen, +886-6-275-7575 ext. 50042
Fax: +886-6-238-9919

Copyright © National Cheng Kung University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

Possible Futures

Superconducting circuits, simplified: New circuit design could unlock the power of experimental superconducting computer chips October 18th, 2014

Nanocoatings Market By Product Is Expected To Reach USD 8.17 Billion By 2020: Grand View Research, Inc. October 15th, 2014

Perpetuus Carbon Group Receives Independent Verification of its Production Capacity for Graphenes at 140 Tonnes per Annum: Perpetuus Becomes the First Manufacturer in the Sector to Allow Third Party Audit October 7th, 2014

PEN Inc. Chairman Scott Rickert Announces Company Vision, Product Priorities and Management Team: Webcast Highlights the Launch of PEN October 3rd, 2014

Academic/Education

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Raytheon, UMass Lowell open on-campus research institute: Industry leaderís researchers to collaborate with faculty, students to move key technologies forward through first-of-its-kind partnership October 11th, 2014

SUNY Colleges of Nanoscale Science and Engineering and National Institute for Occupational Safety and Health Announce Expanded Partnership October 2nd, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Nanomedicine

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014

Announcements

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

Nanobiotechnology

Scientists Map Key Moment in Assembly of DNA-Splitting Molecular Machine: Crucial steps and surprising structures revealed in the genesis of the enzyme that divides the DNA double helix during cell replication October 15th, 2014

DNA nano-foundries cast custom-shaped metal nanoparticles: DNA's programmable assembly is leveraged to form precise 3D nanomaterials for disease detection, environmental testing, electronics and beyond October 10th, 2014

Charged graphene gives DNA a stage to perform molecular gymnastics October 9th, 2014

Nanoparticles get a magnetic handle: New method produces particles that can glow with color-coded light and be manipulated with magnets October 9th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE